NASDAQ:PDSB

PDS Biotechnology Stock Gets Nasdaq Extension as Traders Eye PDSB
·

PDS Biotechnology Stock Gets Nasdaq Extension as Traders Eye PDSB

PDS Biotechnology shares closed at $1.16 Tuesday after Nasdaq confirmed the company regained compliance with its $1 minimum bid rule, ending a delisting threat. The stock had traded under $1 for 30 days earlier this year. PDSB’s market value stands at about $64 million. The company continues to face clinical trial and financing risks.
June 3, 2026

Stock Market Today

  • ICG plc Applies for Admission of 2,367 Shares on London Stock Exchange
    June 3, 2026, 7:37 AM EDT. ICG plc has applied for the admission of 2,367 ordinary shares, each valued at 26 1/4 pence, to the London Stock Exchange. This move relates to the vesting of awards under the ICG Omnibus Plan 2020. The shares are set to begin trading on June 8, 2026, and will rank equally with the company's existing issued ordinary shares. The admission marks a procedural step to integrate new shares from employee awards into the market, reflecting ongoing company governance and shareholder relations.